CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization

Experimental Hematology

Volumn 36, Issue 1, 2008, Pages 93-103

  Copland, Ian ^a   Sharma, Kapil ^a,b   Lejeune, Laurence ^a   Eliopoulos, Nicoletta ^a   Stewart, Duncan ^c   Liu, Peter ^d   Lachapelle, Kevin ^b   Galipeau, Jacques ^a,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CLONING; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOST; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MURINAE; MUS;

EID: 37249025746     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.08.032     Document Type: Article

References (46)

1. Alhadlaq A., and Mao J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13 (2004) 436-448
2. Mauney J.R., Volloch V., and Kaplan D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11 (2005) 787-802
3. Zimmet J.M., and Hare J.M. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 100 (2005) 471-481
4. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28 (2000) 875-884
5. Krause D.S., Ito T., Fackler M.J., et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84 (1994) 691-701
6. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (2007) 964-967
7. Iwasaki H., Kawamoto A., Ishikawa M., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113 (2006) 1311-1325
8. Simmons P.J., and Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78 (1991) 2848-2853
9. Waller E.K., Huang S., and Terstappen L. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development. Blood 86 (1995) 710-718
10. Waller E.K., Olweus J., Lund-Johansen F., et al. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 85 (1995) 2422-2435
11. Choong P.F., Mok P.L., Cheong S.K., and Then K.Y. Mesenchymal stromal cell-like characteristics of corneal keratocytes. Cytotherapy 9 (2007) 252-258
12. Espana E.M., Kawakita T., Liu C.Y., and Tseng S.C. CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci 45 (2004) 2985-2991
13. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., and Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133 (1984) 157-165
14. Stella C.C., Cazzola M., De Fabritiis P., et al. CD34-positive cells: biology and clinical relevance. Haematologica 80 (1995) 367-387
15. Eliopoulos N., Al-Khaldi A., Crosato M., Lachapelle K., and Galipeau J. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Gene Ther 10 (2003) 478-489
16. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., and Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
17. Eliopoulos N., Stagg J., Lejeune L., Pommey S., and Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106 (2005) 4057-4065
18. Paquin A., Jaalouk D.E., and Galipeau J. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum Gene Ther 12 (2001) 13-23
19. Al-Khaldi A., Eliopoulos N., Martineau D., Lejeune L., Lachapelle K., and Galipeau J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 10 (2003) 621-629
20. Salomon B., Cohen J.L., Masurier C., and Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol 160 (1998) 708-717
21. Beissbarth T., and Speed T.P. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20 (2004) 1464-1465
22. Young P.E., Baumhueter S., and Lasky L.A. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 85 (2005) 96-105
23. Fina L., Molgaard H.V., Robertson D., et al. Expression of the CD34 gene in vascular endothelial cells. Blood 75 (1990) 2417-2426
24. Okuno Y., Iwasaki H., Huettner C.S., et al. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proc Natl Acad Sci U S A 99 (2002) 6246-6251
25. Gangenahalli G.U., Singh V.K., Verma Y.K., et al. Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev 15 (2006) 305-313
26. Gillis P., Savla U., Volpert O.V., et al. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 112 Pt 12 (1999) 2049-2057
27. Everett A.D., Narron J.V., Stoops T., Nakamura H., and Tucker A. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol 286 (2004) L1194-L1201
28. Emanueli C., Salis M.B., Pinna A., Graiani G., Manni L., and Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106 (2002) 2257-2262
29. Kim H., Li Q., Hempstead B.L., and Madri J.A. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 279 (2004) 33538-33546
30. Liu C.H., and Hwang S.M. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32 (2005) 270-279
31. Phinney D.G., Hill K., Michelson C., et al. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 24 (2006) 186-198
32. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., and Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198 (2006) 54-64
33. Tanaka K., Hiraiwa N., Hashimoto H., Yamazaki Y., and Kusakabe M. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int J Cancer 108 (2004) 31-40
34. Gengrinovitch S., Berman B., David G., Witte L., Neufeld G., and Ron D. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 274 (1999) 10816-10822
35. Kasai A., Shintani N., Oda M., et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325 (2004) 395-400
36. Ohneda O., Ohneda K., Arai F., et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 98 (2001) 2134-2142
37. Parker L.H., Schmidt M., Jin S.W., et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428 (2004) 754-758
38. Shoji W., Isogai S., Sato-Maeda M., Obinata M., and Kuwada J.Y. Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos. Development 130 (2003) 3227-3236
39. Lazarova P., Wu Q., Kvalheim G., et al. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int J Immunopathol Pharmacol 19 (2006) 49-56
40. Byers B.A., and Garcia A.J. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 10 (2004) 1623-1632
41. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., and Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 (2000) 2-12
42. Lee J.S., Thomas D.M., Gutierrez G., Carty S.A., Yanagawa S., and Hinds P.W. HES1 cooperates with pRb to activate RUNX2-dependent transcription. J Bone Miner Res 21 (2006) 921-933
43. Zebboudj A.F., Shin V., and Bostrom K. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90 (2003) 756-765
44. Li T.S., Hamano K., Nishida M., et al. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285 (2003) H931-H937
45. Breitbach M., Bostani T., Roell W., et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369
46. Liu J.W., Dunoyer-Geindre S., Serre-Beinier V., et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 5 (2007) 826-834